Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient focused benefit risk assessment�� why when how should epidemiologists get
… is not dead, but in this webinar, Ken Rothman shares why it should be. Although seemingly quantitative, statistical … Join us for this webinar where you’ll learn: To articulate why a P-value is a “confounded” measure, mixing effect size …
… cancer susceptibility genes are known to increase the risk of inheriting breast cancer. Genetic testing enables … and sponsored by Pfizer, investigators assessed how genetic counseling is utilized in patient care. Based on data extracted from medical records, …
… Mounting Evidence Suggests Century-Old Hypothesis on How Major Arteries Function is Incorrect Share on: September …
… is not dead, but in this webinar, Ken Rothman shares why it should be. Although seemingly quantitative, statistical … Join us for this webinar where you’ll learn: To articulate why a P-value is a “confounded” measure, mixing effect size …
… osteoporosis in post-menopausal women at high risk for fracture. Because research had shown that the drug … studies in the US and the five Nordic countries. When the indication later expanded to men and younger adults, a prospective, single-arm, patient registry was required. Two comparative studies using …
… by the quality of our questions and comments, but also how cohesive as a team we came across and presented … giving some thoughts on this, I’m always a bit concerned when agencies do not get back at all. Frank Distler Senior Director, Business …
… enhance readability. Use tables and figures to convey data when possible. Update the dossier when there are significant … important timeline information and information relevant to patient access. Include RWE that contributes significantly to … will need accurate, evidence-based, and scientifically focused materials to help communicate a product’s key …
… Using Real-World Data A Challenge of Real World Data: How to Assign Individuals to a Treatment Strategy When Their Data Are Consistent With Several Treatment … Baseline Garcia-Albeniz X , Hsu J, Hernan MA Transcript: When using observational data, quantifying the effect of …
… Labeling The last decade has seen an increased focus on patient-centered drug development. Product labeling based on … to drug manufacturers. The Patient-Centered Outcomes Assessment team at RTI Health Solutions has analyzed FDA PRO … highlight some key observations found during the review. Why listen in? Knowing the trends and the lessons learned …
… RTI-HS Researchers Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share … November 10, 2020 Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated to create this research … data. They drew on current FDA recommendations for patient-focused drug development (PFDD) and other more emergent …